Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Brain Abscess l: Introduction

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Redesigning CAR therapy to tackle immune effector cell-associated hematotoxicity.

Annals of hematology·2026

Same author

Organ-on-chip for advancing CAR therapy.

Clinical & translational immunology·2025

Same author

Editorial: Plant-based drugs: the potential novel therapeutic intervention against cancer stemness and metastasis.

Frontiers in pharmacology·2023

Same author

Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.

Frontiers in immunology·2023

Same author

CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?

Cancer immunology, immunotherapy : CII·2022

Same author

Engineering off-the-shelf universal CAR T cells: A silver lining in the cloud.

Cytokine·2022

Search research articles

相关实验视频

Updated: Jun 2, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

为生成CD19CAR-T细胞的本土工作流程

Muthuganesh Muthuvel^1,2, Sunil Martin³

¹Laboratory of Synthetic Immunology, Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Biotechnology Research Innovation Council, Thiruvananthapuram, Kerala, India.

Methods in molecular biology (Clifton, N.J.)

|September 30, 2025

概括

本研究提出了一种简化,具有成本效益的本土协议,用于产生CD19 CAR T细胞. 这种方法旨在提高B细胞恶性瘤的可访问性,解决当前CAR T细胞疗法的局限性.

关键词:

抗瘤功能的作用 CD19 卡尔-T 细胞流动细胞计量流动细胞计量林氏病毒的生产.

更多相关视频

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

相关实验视频

Last Updated: Jun 2, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Efficient and Rapid Generation of CAR-T and Cytokine-Induced Killer Cells in GMP-scalable Devices

Published on: December 5, 2025

科学领域:

免疫学免疫学免疫学
细胞和基因疗法细胞和基因疗法
在瘤学瘤学.

背景情况:

经FDA批准的CD19 CAR T细胞疗法对B细胞恶性瘤有希望,但面临挑战.
限制包括免疫效应细胞相关的神经毒性综合征 (ICANS),血液毒性 (ICAHTs),高成本和复杂的物流.
这些因素阻碍了患者广泛获得CAR T细胞疗法.

研究的目的:

为CAR T细胞生成和表征开发一个安全,成本效益和简化的本地工作流程.
优化一种从健康捐献者的外周血液T细胞中生产CD19 CAR T细胞的方法.
通过提供可复制的协议,促进临床前和临床研究.

主要方法:

优化用于T细胞扩张和基因修饰的lentiviral转导协议.
开发一种本土的工作流程,用于产生CD19 CAR T细胞.
为免疫学评估和下游应用而生成的CD19 CAR T细胞的表征.

主要成果:

从健康的外周血液T细胞捐赠者中开发CD19 CAR T细胞的优化方法已经建立.
该协议为CAR T细胞生成提供了一种简化且具有成本效益的方法.
产生的细胞适用于免疫学研究和潜在的下游应用.

结论:

开发的本土协议为生产CD19 CAR T细胞提供了可行的解决方案.
这个工作流程解决了与当前CAR T细胞疗法相关的可访问性问题.
该协议支持进一步研究CAR T细胞免疫学和临床应用.